AVTR Company Profile and Key Details

Q: Who are the executives of AVTR?

Ms. Allison K. HosakSenior Vice President of Global Communications & BrandMr. Justin M. Miller Esq.Executive Vice President, Gen. Counsel & Sec.Mr. Michael StubblefieldPres, Chief Executive Officer & DirectorMr. R. Brent JonesExecutive Vice President & Chief Financial OfficerMs. Sheri LewisExecutive Vice President of Global Supply ChainMr. Frederic VanderhaegenExecutive Vice President of EuropeMr. Michael WondraschExecutive Vice President & Chief Information OfficerDr. Gerard Brophy Ph.D.Executive Vice President of Biopharma ProductionMr. Steven W. EckSenior Vice President, Corporation Controller & Chief Accounting OfficerMs. Kitty SahinExecutive Vice President of Strategy & Corporation Devel.Mr. Claudius O. SokenuSenior Vice President, Gen. Counsel, Corporation Sec. & Chief Admin. OfficerMr. Tommy J. Thomas CPAVice President of Investor Relations

NYSE : AVTR

Avantor

$11.16

-0.07-0.62%

At Close 4:00 PM

$11.16

0.000.00%

After-Market 08:30 PM

69.13

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Avantor, Inc. (AVTR) stock declined over -0.62%, trading at $11.16 on NYSE, down from the previous close of $11.23. The stock opened at $11.34, fluctuating between $11.04 and $11.34 in the recent session.

Stock Snapshot

11.23

Prev. Close

7.61B

Market Cap

11.04

Day Low

-85.85

P/E Ratio

-0.13

EPS (TTM)

1.07

Cash Flow per Share

11.34

Open

681.81M

Number of Shares

11.34

Day High

97.39%

Free Float in %

7.77

Book Value

28.62M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 10, 2026	11.34	11.34	11.04	11.16	28.61M
Feb 09, 2026	11.12	11.35	10.98	11.23	8.9M
Feb 06, 2026	11.15	11.26	10.92	11.26	10.5M
Feb 05, 2026	11.10	11.20	10.67	10.79	11.57M
Feb 04, 2026	11.04	11.26	10.90	11.14	18.16M
Feb 03, 2026	10.94	11.34	10.72	10.85	13.6M
Feb 02, 2026	10.79	11.10	10.79	11.07	9.63M
Jan 30, 2026	10.72	10.98	10.70	10.92	10.7M
Jan 29, 2026	11.01	11.01	10.67	10.81	20.13M
Jan 28, 2026	11.62	11.64	11.02	11.05	17.41M
Jan 27, 2026	11.60	11.89	11.48	11.65	12.18M
Jan 26, 2026	11.81	11.91	11.77	11.79	15.31M
Jan 23, 2026	12.08	12.22	11.69	11.80	13.9M
Jan 22, 2026	12.29	12.51	12.21	12.24	14.05M
Jan 21, 2026	11.94	12.23	11.85	12.21	7.82M
Jan 20, 2026	11.86	12.13	11.74	11.85	10.31M
Jan 16, 2026	11.98	12.21	11.87	12.16	9.17M
Jan 15, 2026	12.36	12.39	11.78	12.02	10.71M
Jan 14, 2026	12.66	12.90	11.92	12.38	14.4M
Jan 13, 2026	12.50	12.84	12.09	12.60	10.61M

Contact Details

Radnor, PA 19087

United States

https://www.avantorsciences.com 610 386 1700

About Company

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Stock Peers

RMD

-12.42-4.50%

ResMed Inc.$263.54 WST

-5.37-2.16%

West Pharmaceutical Services, Inc.$243.56 BDX

8.701+5.34%

Becton, Dickinson and Company$171.68 ATR

1.7+1.23%

AptarGroup, Inc.$140.17 TFX

-0.35-0.33%

Teleflex Incorporated$105.86 ALC

2.04+2.60%

Alcon Inc.$80.48 HAE

1.77+3.07%

Haemonetics Corporation$59.46 WRBY

-1.64-6.79%

Warby Parker Inc.$22.50 BAX

0.21+0.97%

Baxter International Inc.$21.94 BLCO

0.24+1.42%

Bausch + Lomb Corporation$17.15

Company Overview

Avantor, Inc. (NYSE:AVTR) closed at $11.16 USD, losing -$0.07 (-0.62%) from the previous close of $11.23. The stock is currently mid-range between its 52-week high and low $10.62 and $18.82. With a market capitalization of about $7.61 billion, Avantor, Inc. is classified as a mid-cap and shows market-like volatility (beta ~0.95). Key stats such as the average daily volume over the past year has been around 10.67 million shares, trading with heavier-than-usual volume. Headquartered in Radnor, PA, Avantor, Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Emmanuel Ligner, the company employs approximately 13,500 people and listed since May 17, 2019. Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -3.37%, SMA50 -2.93%, SMA200 -11.27%). The stock’s 14-day RSI is 45.14 (neutral), while the ATR of 0.42 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -42.84% below its high and over 5.08% above its low. Average 10-day trading volume of 14.42 million shares is slightly above the 3-month average of 10.14 million, indicating heightened recent market interest.

Valuation Metrics

Avantor, Inc. trades at a P/E ratio of -92.93, slightly below the S&P 500 average, with a price-to-sales ratio of 1.16 and a price-to-book ratio of 1.37 suggesting the stock is closer to book value. The P/FCF stands at 14.59, also below market averages.

Dividend & Fair Value

Avantor, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $30.62. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of -0.49% annually over the next five years. The latest quarter delivered EPS of $0.22. The next quarter is forecast at $0.22. Next year's EPS is expected at $3.75. Analyst sentiment is bullish. Analyst rating data shows there are 18 Strong Buy ratings, 1 Buy ratings, 7 Hold ratings, 0 Sell rating and 1 Strong Sell ratings. Price targets range from $31.00 to $12.00. The high target offers 177.78% upside. The low target suggests 7.53% downside. The mean target is $17.15. This offers 53.67% upside. Avantor, Inc. earnings surprise history is a mixed track record. The quarter that ended October 29, 2025, missed forecasts by -4.35%. The prior quarter beat by -4.0%. Over the last six quarters, Apple has recorded several small beats. These include -104.7% in July 26, 2024.

Shareholding & Insider Activity

Avantor, Inc. has 681.81 million shares outstanding. The public float is 663.76 million shares, elevated short interest at 5.59% of float. This equals 28.02 million shares. The short ratio is 2.7 days. Institutional investors hold 103.71% of the float. Insiders own 1.39%. GOLDMAN SACHS & CO. LLC holds 72.62 million shares, GUPTA RAJIV has 879.35 thousand shares and Natauri Jo has 557.66 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Avantor generated $6.97B in revenue, or $10.27 per share. Gross margin was 33.93%, operating margin 10.00%, and net profit margin 4.61%. Returns are modest, with ROA at 2.48% and ROE at 6.11%.
On valuation metrics, Avantor trades at a P/E of -92.93, P/S of 1.16 and P/B of 1.37. The current ratio is 1.49 and quick ratio is 0.96. Operationally, the company’s inventory turnover is 5.53 and cash conversion cycle is 68.45 days. Debt-to-equity is 0.69, supported by a cash flow-to-debt ratio of 0.17.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Avantor posted revenue of $6.97B, down slightly from $7.51B in the prior quarter. Gross profit was $2.36B (margin 33.93%). Operating income was $696.40M (margin 10.0%). Net income was$321.10M (EPS $0.48).
The company ended the quarter with $262.90M in cash and short-term investments, a total debt of $5.54B, and net debt of $5.27B. Total assets were $12.97B, with equity of $5.25B. Financials further reflected stability, with operating cash flow of $870.00M, free cash flow of $723.60M, and capital expenditures of - $146.40M.

Price Forecast & Outlook

Our AI price prediction model suggests that Avantor, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -9.41%, with price expected at $10.11 by February 23, 2026, within a range of $9.78 to $10.45 3-Month Outlook: Projected fall of -39.34%, reaching $6.77 by May 08, 2026, with a range of $6.29 to $7.19. 1-Year Outlook: Projected gain of 4.12%, with price at $11.62 by February 09, 2027, within a range of $3.89 to $12.96.

Key Takeaways

Avantor, Inc. (NYSE:AVTR) shares are flat 3.4% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Avantor, Inc. trading at a premium to the broader market with a P/E of -92.93. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $25.34, suggesting 127.06% upside. Our AI forecast model points to short-term weakness (-9.41% over two weeks), a medium-term fall (-39.34% over three months), and a longer-term gain (4.12% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Avantor, Inc. (AVTR) stock price?

Avantor, Inc. (NYSE: AVTR) stock price is $11.16 in the last trading session. During the trading session, AVTR stock reached the peak price of $11.34 while $11.04 was the lowest point it dropped to. The percentage change in AVTR stock occurred in the recent session was -0.62% while the dollar amount for the price change in AVTR stock was - $0.07.

AVTR's industry and sector of operation?

The NYSE listed AVTR is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Avantor, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AVTR?

Ms. Allison K. Hosak
Senior Vice President of Global Communications & Brand
Mr. Justin M. Miller Esq.
Executive Vice President, Gen. Counsel & Sec.
Mr. Michael Stubblefield
Pres, Chief Executive Officer & Director
Mr. R. Brent Jones
Executive Vice President & Chief Financial Officer
Ms. Sheri Lewis
Executive Vice President of Global Supply Chain
Mr. Frederic Vanderhaegen
Executive Vice President of Europe
Mr. Michael Wondrasch
Executive Vice President & Chief Information Officer
Dr. Gerard Brophy Ph.D.
Executive Vice President of Biopharma Production
Mr. Steven W. Eck
Senior Vice President, Corporation Controller & Chief Accounting Officer
Ms. Kitty Sahin
Executive Vice President of Strategy & Corporation Devel.
Mr. Claudius O. Sokenu
Senior Vice President, Gen. Counsel, Corporation Sec. & Chief Admin. Officer
Mr. Tommy J. Thomas CPA
Vice President of Investor Relations

How AVTR did perform over past 52-week?

AVTR's closing price is 5.08% higher than its 52-week low of $10.62 where as its distance from 52-week high of $18.82 is -40.7%.

How many employees does AVTR have?

Number of AVTR employees currently stands at 13,500.

Link for AVTR official website?

Official Website of AVTR is: https://www.avantorsciences.com

How do I contact AVTR?

AVTR could be contacted at phone 610 386 1700 and can also be accessed through its website. AVTR operates from Radnor Corporate Center, Radnor, PA 19087, United States.

How many shares of AVTR are traded daily?

AVTR stock volume for the day was 28.62M shares. The average number of AVTR shares traded daily for last 3 months was 10.67M.

What is the market cap of AVTR currently?

The market value of AVTR currently stands at $7.61B with its latest stock price at $11.16 and 681.81M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	13500
Beta	0.95
Sales or Revenue	$6.97B
5Y Sales Change%	-0.127%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Instruments & Supplies

AVTR Company Profile and Key Details

Avantor

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Stock Snapshot

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook

Earnings & Analyst Outlook

Valuation Metrics